Aprea Therapeutics Inc. Common stock is a pharmaceutical company focused on developing novel cancer therapeutics. Its innovative approach centers on reactivating the tumor suppressor protein p53 to induce tumor cell death. With a strong pipeline and promising clinical data, Aprea is poised to make a significant impact in the field of oncology.
Notification